Biotech Today: An Investor’s Perspective-Anand Mehra, MD-02/12/2013 - 6:00pm

Event Information
Event Topic: 
Biotech Today: An Investor’s Perspective
Event Date: 
02/12/2013 - 6:00pm
Event Location: 
Wilson Sonsini Goodrich & Rosati, 650 Page Mill Road, Palo Alto CA
Speaker Information
Event Speaker: 
Anand Mehra, MD
Event Speaker Title: 
Partner
Event Speaker Company: 
Sofinnova Ventures
Event Speaker Bio: 

Anand Mehra

Anand joined Sofinnova Ventures in 2007 to focus on biopharmaceutical investing. Anand’s diverse background equips him to work with entrepreneurs on scientific, clinical, and strategic levels. Currently, he is a director of Marinus, Aerie and former director of Nextwave Pharmaceuticals (Acquired: Pfizer), and Vicept (Acquired: Allergan). Anand also played an important role in the firm’s investments in Hyperion (NASDAQ: HPTX), Preglem (Acquired: Gedeon Richter), and Amarin (NASDAQ: AMRN).

Prior to joining Sofinnova Ventures, Anand worked in JP Morgan’s private equity and venture capital group, where he was heavily involved in new investments, management of their public portfolio, and the firm’s spin-out from the bank. Before joining the venture community, Anand was a consultant in McKinsey & Company's pharmaceutical practice, advising pharma and biotech on key strategic issues, and an NIH-funded Fellow focused on reperfusion injury in stroke.

Anand received his M.D. from Columbia Medical School and graduated Phi Beta Kappa from the University of Virginia.

Event Details
Cost: 
$6 - Students/In-transition - Members only
$11 - Early-bird Registration - Members only
$20 - Late Registration and Non-Members
$25 - Walk-ins
Event Details: 

Topic: “Biotech Today: An Investor’s Perspective”
Speaker: Anand Mehra, MD, Partner, Sofinnova Ventures
Date and Time: Tuesday, Feb. 12, 2013, 6:00 – 9:00 pm
Location: Wilson Sonsini Goodrich & Rosati, 650 Page Mill Road, Palo Alto CA
Cost:
$6 - Students/In-transition - Members only
$11 - Early-bird Registration - Members only
$20 - Late Registration and Non-Members
$25 - Walk-ins

Topic Description
Biotech investing has gone through several investment cycles in the past decade. In this talk, the speaker will review those cycles, his prediction for what the future holds, and provide advice on building companies in today’s world.